Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 12,676 shares at $32.43 ($410K) on 2021-06-28, disclosed to the SEC on 2021-06-30.
Open-market sale of $410k MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.23 | 1,891 | $61K | 14.9% |
| 2 | $32.23 | 1,891 | $61K | 14.9% |
| 3 | $32.43 | 3,973 | $129K | 31.4% |
| 4 | $32.43 | 3,973 | $129K | 31.4% |
| 5 | $32.49 | 948 | $31K | 7.5% |
| Total | $32.37 avg | 12,676 |
| $410K |
| 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |